$FAMI

Farmmi Receives NASDAQ Notification Regarding Minimum Bid Requirements

Farmmi, Inc. (NASDAQ: FAMI) said Nasdaq notified it on Aug. 11, 2026 that it is not meeting the $1.00 minimum bid price requirement because its Class A share closing bid stayed below $1 for 30 straight business days. Nasdaq granted a 180-day compliance period until Feb. 8, 2027, with possible reverse split option.

Original reporting
Published Aug 12, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$FAMI
Bearish
medium confidence
Mentioned
$FAMI
Relevance
7/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$FAMIBearishMed
01

Why it matters

Farmmi has 180 calendar days, until Feb 8, 2027, to regain compliance by sustaining a $1.00 closing bid for at least 10 consecutive business days, or by completing a reverse split within the specified window.

02

Market read

This is a defined listing-compliance catalyst with a time-bound cure period and a reverse-split pathway, which can materially affect trading behavior and risk pricing.

03

What to watch

The release does not state current bid levels or liquidity trends beyond the 30-day below-$1 condition, so traders should verify whether the stock is already trending toward $1 compliance.

Relevance 7/10Novelty 7/10Timing: after-hours disclosure Aug 12, 2026, with a 180-day compliance clock starting from the Aug 11 deficiency letter

Background

Nasdaq Listing Rule 5550(a)(2) requires a minimum bid price of $1.00; Farmmi received a deficiency notice under Rule 5810(b).

Company-level read

Ticker impact

$FAMIBearishMedium confidence
Context

Farmmi disclosed Nasdaq notified it is not compliant with the $1.00 minimum bid rule after 30 consecutive business days below $1.

Expected impact

Expect elevated volatility and downside risk until the company signals whether it will pursue a reverse split or regains $1 bid compliance.

Evidence & confidence

The filing is a direct listing compliance event with a defined 180-day cure window and explicit reverse-split option, which typically pressures microcap liquidity and sentiment.

Market effects

Microcap listing-compliance headlines can spill into sentiment for other thinly traded Nasdaq small caps, but this is company-specific.

Limited direct regional contagion; the event is driven by Nasdaq listing rules rather than China-specific fundamentals.

Low global relevance; primarily affects US-listed trading liquidity and delisting risk pricing for FAMI.

Counterpoint

If Farmmi can quickly lift the bid above $1 for 10 consecutive business days, the overhang could fade well before any reverse split is needed.

Key entities

  • Farmmi, Inc.

    Nasdaq-listed agricultural products supplier that received the minimum bid deficiency notice.

  • The Nasdaq Stock Market LLC

    Exchange entity issuing the deficiency notification under Nasdaq listing rules.

Related articles

$FAMIMed

Farmmi, Inc. Announces Launch of Proposed Public Offering

Farmmi, Inc. (NASDAQ: FAMI) said it intends to launch a proposed public offering of Class A ordinary shares. The company plans to use net proceeds for general corporate and working capital, according to the release. Aegis Capital Corp. will serve as sole book-running manager. The offering is subject to market conditions and will be made under an SEC shelf registration statement.

Can SK hynix shares hit 3 million won again? Why Solidigm dropped its IPO plans

SK Hynix withdrew Solidigm's NASDAQ IPO to avoid shareholder value erosion from duplicate listings. The move is expected to improve investor sentiment and stock price, which had declined 33.28% from January 1 to February 22. SK Hynix's stock rebounded 4.42% following the announcement, closing at 1.277 million won. Analysts anticipate further stock price improvement due to shareholder return measures and historic low valuations.